| [1] |
倪艳霞. 黄连素治疗Ⅱ型糖尿病60例疗效观察及实验研究[J].中国中西医结合杂志,1988,8(12):711-713.
|
| [1] |
倪艳霞. 黄连素治疗Ⅱ型糖尿病60例疗效观察及实验研究[J].中国中西医结合杂志,1988,8(12):711-713.
|
| [2] |
王 强.黄连素片治疗糖尿病的体会[J].中医药信息,2008,2:35.
|
| [2] |
王 强.黄连素片治疗糖尿病的体会[J].中医药信息,2008,2:35.
|
| [3] |
陈德元.黄连素治疗2 型糖尿病50 例观察[J].现代中西医结合杂志,2012,10(2):138-139.
|
| [3] |
陈德元.黄连素治疗2 型糖尿病50 例观察[J].现代中西医结合杂志,2012,10(2):138-139.
|
| [4] |
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J].J Chin Pharmaceutical Sciences,2011,16(4):300-306.
|
| [4] |
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J].J Chin Pharmaceutical Sciences,2011,16(4):300-306.
|
| [5] |
于棉荣,张少时,张佩文,等.黄连素治疗糖尿病105例疗效观察[J].中国民间疗法,1996,3:31-32.
|
| [5] |
于棉荣,张少时,张佩文,等.黄连素治疗糖尿病105例疗效观察[J].中国民间疗法,1996,3:31-32.
|
| [6] |
石利天,张瑞增.黄连素治疗68例2 型糖尿病的临床评价[J].山西临床医药杂志,2011,9(3):181-182.
|
| [6] |
石利天,张瑞增.黄连素治疗68例2 型糖尿病的临床评价[J].山西临床医药杂志,2011,9(3):181-182.
|
| [7] |
Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J].Metabolism,2008,57(5):712-717.
|
| [7] |
Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J].Metabolism,2008,57(5):712-717.
|
| [8] |
李 真.生地黄连液对四氧嘧啶小鼠影响的研究[J].辽宁中医杂志,2000,27(12):574.
|
| [8] |
李 真.生地黄连液对四氧嘧啶小鼠影响的研究[J].辽宁中医杂志,2000,27(12):574.
|
| [9] |
陈其明,谢明智.黄连及黄连素降血糖作用的研究[J].药学学报,1986,21(6):401.
|
| [9] |
陈其明,谢明智.黄连及黄连素降血糖作用的研究[J].药学学报,1986,21(6):401.
|
| [10] |
Lee Y S, Kim W S, Kim K H, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J].Diabetes,2012,55(8): 2256- 2264.
|
| [10] |
Lee Y S, Kim W S, Kim K H, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J].Diabetes,2012,55(8): 2256- 2264.
|
| [11] |
Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizome[J]. Biol Pharm Bull,2005,28:1431-1437.
|
| [11] |
Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizome[J]. Biol Pharm Bull,2005,28:1431-1437.
|
| [12] |
Cheng Z, Pang T, Gu M, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J]. Biochim Biophys Acta,2006,1760:1682-1689.
|
| [12] |
Cheng Z, Pang T, Gu M, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J]. Biochim Biophys Acta,2006,1760:1682-1689.
|
| [13] |
Zhou L, Yang Y, Wang X, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin[J]. Metabolism,2010,56:405-412.
|
| [13] |
Zhou L, Yang Y, Wang X, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin[J]. Metabolism,2010,56:405-412.
|
| [14] |
Kim S H, Shin E J, Kim E D, et al. Berberine activates GLUT1-Mediated glucose uptake in 3T3-L1 adipocytes[J].Biol Pharm Bull,2007,30:2120-2125.
|
| [14] |
Kim S H, Shin E J, Kim E D, et al. Berberine activates GLUT1-Mediated glucose uptake in 3T3-L1 adipocytes[J].Biol Pharm Bull,2007,30:2120-2125.
|
| [15] |
Kong L D, Cheng C H, Tan R X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis[J]. Planta Med,2011,67:74-76.
|
| [15] |
Kong L D, Cheng C H, Tan R X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis[J]. Planta Med,2011,67:74-76.
|
| [16] |
Pospisilik J A, Knauf C, Joza N, et al.Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes[J].Cell,2007,131:476-491.
|
| [16] |
Pospisilik J A, Knauf C, Joza N, et al.Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes[J].Cell,2007,131:476-491.
|
| [17] |
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol -lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2012,10(12):1344-1351.
|
| [17] |
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol -lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2012,10(12):1344-1351.
|
| [18] |
Cicero A F, Rovati L C, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol -lowering agents. A single-blind clinical investigation[J]. Arzneimittelforschung,2007,57:26-30.
|
| [18] |
Cicero A F, Rovati L C, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol -lowering agents. A single-blind clinical investigation[J]. Arzneimittelforschung,2007,57:26-30.
|
| [19] |
Yin J, Chen M, Tang J,et al. Effects of berberine on glucose and lipid metabolism in animal experiment[J]. Chin J Diabetes,2004,12(3):215-218.
|
| [19] |
Yin J, Chen M, Tang J,et al. Effects of berberine on glucose and lipid metabolism in animal experiment[J]. Chin J Diabetes,2004,12(3):215-218.
|
| [20] |
Leng S H, Lu F E, Xu L J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion[J]. Acta Pharmacol Sin,2004,25(4):496-502.
|
| [21] |
勾祥辉.黄连素治疗高血脂59例[J].人民军医,2008,2(1):35.
|
| [20] |
Leng S H, Lu F E, Xu L J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion[J]. Acta Pharmacol Sin,2004,25(4):496-502.
|
| [21] |
勾祥辉.黄连素治疗高血脂59例[J].人民军医,2008,2(1):35.
|
| [22] |
宋菊敏,毛 良,施建玲,等.黄连素对非胰岛素依赖性糖尿病大鼠的抗氧化作用[J].中草药,1992,23(11):590.
|
| [22] |
宋菊敏,毛 良,施建玲,等.黄连素对非胰岛素依赖性糖尿病大鼠的抗氧化作用[J].中草药,1992,23(11):590.
|
| [23] |
殷 峻,陈明道,唐金凤,等.黄连素对实验大鼠糖脂代谢的影响[J].中华糖尿病杂志,2012,12(3):215-218.
|
| [23] |
殷 峻,陈明道,唐金凤,等.黄连素对实验大鼠糖脂代谢的影响[J].中华糖尿病杂志,2012,12(3):215-218.
|
| [24] |
Rosen E D, MacDougald O A. Adipocyte differentiation from the inside out[J].Nat Rev Mol Cell Biol,2006,7(12):885-896.
|
| [24] |
Rosen E D, MacDougald O A. Adipocyte differentiation from the inside out[J].Nat Rev Mol Cell Biol,2006,7(12):885-896.
|
| [25] |
Abidi P, Zhou Y, Jiang JD,et al.Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine[J]. Arterioscler Thromb Vasc Biol,2005,25(10):2170-2176.
|
| [25] |
Abidi P, Zhou Y, Jiang JD,et al.Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine[J]. Arterioscler Thromb Vasc Biol,2005,25(10):2170-2176.
|
| [26] |
Lee S, Lim H J, Park H Y,et al.Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo[J]. Atherosclerosis,2006,186(1):s29-37.
|
| [26] |
Lee S, Lim H J, Park H Y,et al.Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo[J]. Atherosclerosis,2006,186(1):s29-37.
|
| [27] |
Liang K W, Ting C T, Yin S C, et al. Berberine suppresses MEK/ERKdependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury[J].Biochem Pharmacol,2006,71(6):806-817.
|
| [27] |
Liang K W, Ting C T, Yin S C, et al. Berberine suppresses MEK/ERKdependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury[J].Biochem Pharmacol,2006,71(6):806-817.
|
| [28] |
Lee S, Lim H J, Park J H,et al. Berberine-induced LDLR up-regulation involves JNK pathway[J].Biochem Biophys Res Commun,2007,362(4):853-857.
|
| [28] |
Lee S, Lim H J, Park J H,et al. Berberine-induced LDLR up-regulation involves JNK pathway[J].Biochem Biophys Res Commun,2007,362(4):853-857.
|
| [29] |
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J]. J Chin Pharmaceutical Sciences,2011,16(4):300-306.
|
| [29] |
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J]. J Chin Pharmaceutical Sciences,2011,16(4):300-306.
|
| [30] |
Choi B H, Ahn I S, Kim Y H, et al. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte[J]. Exp Mol Med,2012,38(6):599-605.
|
| [30] |
Choi B H, Ahn I S, Kim Y H, et al. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte[J]. Exp Mol Med,2012,38(6):599-605.
|
|
|
2014, Vol. 25 
